NCT01671865View on ClinicalTrials.gov

Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy

Active, not recruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Facioscapulohumeral Muscular Dystrophy
Trial Locations (1)

21205

Doris Leung, Baltimore

All Listed Sponsors
lead

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

NCT01671865 - Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy | Biotech Hunter | Biotech Hunter